NCT03116672View on ClinicalTrials.gov

The Outcome of Preoperative Administration of Single-dose Ketorolac, Non-steroidal Anti-inflammatory Drug and Placebo

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 2, 2016

Primary Completion Date

February 6, 2017

Study Completion Date

February 10, 2017

Conditions
Pulpitis - Irreversible
Interventions
DRUG

one dose ketorolac 10 mg

Administration of ketorolac 10mg, (Dolac) 15 minutes before the clinical procedure.

DRUG

One dose Diclofenac

Administration of diclofenac, (Diclofenaco) 15 minutes before the clinical procedure.

DRUG

Placebo oral capsule

Administration of Placebo, 15 minutes before the clinical procedure.

Trial Locations (1)

22000

Jose Clemente, Tijuana

All Listed Sponsors
lead

Universidad Autonoma de Baja California

OTHER

NCT03116672 - The Outcome of Preoperative Administration of Single-dose Ketorolac, Non-steroidal Anti-inflammatory Drug and Placebo | Biotech Hunter | Biotech Hunter